Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports

Pfizer’s oral antiviral drug paxlovid significantly reduces hospital admissions and deaths among people with covid-19 who are at high risk of severe illness, when compared with placebo, the company…


Read Original Article: Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports »